2009 Fiscal Year Final Research Report
Development of personalized medicine and therapeutic strategies for pediatric solid tumors
Project/Area Number |
17015046
|
Research Category |
Grant-in-Aid for Scientific Research on Priority Areas
|
Allocation Type | Single-year Grants |
Review Section |
Biological Sciences
|
Research Institution | Chiba Cancer Center (Research Institute) |
Principal Investigator |
NAKAGAWARA Akira Chiba Cancer Center (Research Institute), センター長 (50117181)
|
Project Period (FY) |
2005 – 2009
|
Keywords | 小児がん / 個別化診断 / 個別化治療 / 神経芽腫 / DNAチップ |
Research Abstract |
We have aimed to establish new diagnostic systems to predict prognosis of neuroblastoma and hepatoblastoma, which are typical childhood solid tumors, by using comprehensive methodology including genomics and proteomics. The childhood cancers-proper cDNA libraries we generated previously and the BAC clones-based array-CGH methods were introduced. We could successfully generate a practically usable mini-chip carrying top ranked 200 genes to predict the prognosis of neuroblastoma. In addition, our array-CGH analysis made it possible to generate a genome-based risk classification of neuroblastoma which is now applicable to the clinical study. The novel serum prognostic factors have also been identified. Furthermore, we found new neuroblastoma genes including KIF1Bbeta, RUNX3 and ALK which is often amplified and mutated in primary neuroblastomas.
|
Research Products
(81 results)
-
-
-
[Journal Article] Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature.2010
Author(s)
De Katleen P, Vermeulen J, Brors B, Delattre O, Eggert A, Fischer M, Janoueix-Lerosey I, Lavarino C, Maris JM, Mora J, Nakagawara A, Oberthuer A, Ohira M, Schleiermacher G, Schramm A, Schulte JH, Wang Q, Westermann F, Speleman F, Vandesompele J.
-
Journal Title
Clin. Cancer Res. 16
Pages: 1532-1541
Peer Reviewed
-
[Journal Article] Bmil is a MYCN target gene and regulates tumorigenesis via repression of KIF1B 13 and TSLC1 in neuroblastoma.2010
Author(s)
Ochiai H, Takenobu H, Nakagawa A, Yamaguchi Y, Kimura M, Ohira M, Okimoto Y, Fujimura Y, Koseki H, Kohno Y, Nakagawara A, Kami jo T.
-
Journal Title
Oncogene 29
Pages: 2681-2690
Peer Reviewed
-
[Journal Article] RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a Co-activator for p53.2010
Author(s)
Yamada C, Ozaki T, Ando K, Suenaga Y, Inoue Kt, Ito Y, Okoshi R, Kageyama H, Kimura H, Miyazaki M, Nakagawara A.
-
Journal Title
J. Biol. Chem. 285
Pages: 16693-166703
Peer Reviewed
-
-
-
[Journal Article] International consensus for neuroblastoma molecular diagnostics: Report from the international neuroblastoma risk group (INRG) biology committee.2009
Author(s)
Ambros PF, Ambros TM, Brodeur GM, Haber M, Khan J, Nakagawara A, Schleiermacher G, Speleman F, Spitz R, London WB, Cohn SL, Pearson ADJ, Maris JM.
-
Journal Title
Br. J. Cancer 100
Pages: 1471-1482
Peer Reviewed
-
[Journal Article] Netrin-1 acts as a survival factor for aggressive neuroblastoma.2009
Author(s)
Delloye-Bourgeois C, Fitamant J, Paradisi A, Cappellen D, Douc-Rasy S, Raquin MA, Stupack D, Nakagawara A, Rousseau R, Combaret V, Puisieux A, Valteau-Couanet D, Benard J, Bernet A, Mehlen P.
-
Journal Title
J. Exp. Med. 206
Pages: 833-847
Peer Reviewed
-
[Journal Article] Plkl regulates liver tumor cell death by phosphorylation of TAp63.2009
Author(s)
Komatsu S, Takenobu H, Ozaki T, Ando K, Koida N, Suenaga Y, Ichikawa T, Hishiki T, Chiba T, Iwama A, Yoshida H, Ohnuma N, Nakagawara A, Kamijo T.
-
Journal Title
Oncogene 28
Pages: 3631-3641
Peer Reviewed
-
-
-
[Journal Article] P1k3 inhibits pro-apoptotic activity of p73 through physical interaction and phosphorylation.2009
Author(s)
Sang M, Ando K, Okoshi R, Koida N, Li Y, Zhu Y, Shimozato O, Geng C, Shan B, Nakagawara A, Ozaki T.
-
Journal Title
Genes Cells 14
Pages: 775-788
Peer Reviewed
-
-
-
-
-
-
-
-
[Journal Article] Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature.2008
Author(s)
Tomioka N, Oba S, Ohira M, Misra A, Fridly, J, Ishii S, Nakamura Y, Isogai E, Hirata T, Yoshida Y, Todo S, Kaneko Y, Albertson DG, Pinkel D, Feuerstein BG, Nakagawara A.
-
Journal Title
Oncogene 27
Pages: 441-449
Peer Reviewed
-
-
-
-
-
-
-
-
[Journal Article] The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients.2008
Author(s)
Honda S, Haruta M, Sugawara W, Sasaki F, Ohira M, Matsunaga T, Yamaoka H, Horie H, Ohnuma N, Nakagawara A, Hiyama E, Todo S, Kaneko Y.
-
Journal Title
Int. J. Cancer 123
Pages: 1117-1125
Peer Reviewed
-
-
-
-
-
[Journal Article] Alterations in the glycoform of cisplatin-resistant human carcinoma cells are caused by defects in the endoplasmic reticulum-associated degradation system.2008
Author(s)
Nakagawa H, Ohira M, Hayashi S, Abe S, Saito S, Nagahori N, Monde K, Shinohara Y, Fujitani N, Kondo H, Akiyama S, Nakagawara A, Nishimura S.
-
Journal Title
Cancer Lett. 270
Pages: 295-301
Peer Reviewed
-
-
[Journal Article] Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation.2008
Author(s)
Ando K, Ohira M, Ozaki T, Nakagawa A, Akazawa K, Suenaga Y, Nakamura Y, Koda T, KamijoT, Murakami Y, Nakagawara A.
-
Journal Title
Int. J. Cancer 123
Pages: 2087-2094
Peer Reviewed
-
-
[Journal Article] Oncogenic mutations of ALK kinase in neuroblastoma.2008
Author(s)
Chen Y, Takita J, Choi YL, Kato M, Ohira M, Sanada M, Wang L, Soda M, Kikuchi A, Igarashi T, Nakagawara A, Hayashi Y, Mano H, Ogawa S.
-
Journal Title
Nature 455
Pages: 971-974
Peer Reviewed
-
-
[Journal Article] Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma.2008
Author(s)
Honda S, Arai Y, Haruta M, Sasaki F, Ohira M, Yamaoka H, Horie H, Nakagawara A, Hiyama E, Todo S, Kaneko Y.
-
Journal Title
Br. J. Cancer 99
Pages: 1891-1899
Peer Reviewed
-
[Journal Article] High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25. 1, is associated with poor prognosis in neuroblastoma.2008
Author(s)
Yu M, Ohira M, Li Y, Niizuma H, Oo ML, Zhu Y, Ozaki T, Isogai E, Nakamura Y, Koda T, Oba S, Yu B, Nakagawara A.
-
Journal Title
Int. J. Oncol. 34
Pages: 931-938
Peer Reviewed
-
-
[Journal Article] Reciprocal expression of CCAAT/enhancer binding proteins a and b in hepatoblastomas and its prognostic significance. Once].2007
Author(s)
Tomizawa M, Horie H, Yamamoto H, Matsunaga T, Sasaki F, Hashizume K, Hiyama E, Kaneko M, Suita S, Ando H, Hayashi Y, Ohnuma N, Nakagawara A.
-
Journal Title
Reciprocal expression of CCAAT/enhancer binding proteins a and b in hepatoblastomas and its prognostic significance. Oncel. Rep. 17
Pages: 341-344
Peer Reviewed
-
-
-
-
-
-
[Journal Article] Silencing Ku80 using small interfering RNA enhanced radiation sensitivity in vitro and in vivo.2007
Author(s)
Nimura Y, Kawata T, Uzawa K, Okamura J, Liu C, Saito M, Shimada H, Seki N, Nakagawara A, Ito H, Ochiai T, Tanzawa H.
-
Journal Title
Int. J. Oncol. 30
Pages: 1477-1484
Peer Reviewed
-
-
-
-
-
-
-
-
-
[Journal Article] Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas.2006
Author(s)
Machida T, Fujita T, Ooo M L, Ohira M, Isogai E, Mihara M, Hirato J, Tomotsune D, Hirata T, Fujimori M, Adachi W, Nakagawara A.
-
Journal Title
Oncogene 25
Pages: 1931-1942
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Topors, a p53 and topoisomerase I-binding RING finger protein, is a co-activator of p53 in growth suppression induced by DNA damage.2005
Author(s)
Lin L, Ozaki T, Takada Y, Kageyama H, Nakamura Y, Hata A, Zhang J-H, Simonds W, Nakagawara A, Koseki H.
-
Journal Title
Oncogene 24
Pages: 3385-3396
Peer Reviewed
-
-
[Journal Article] Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas.2005
Author(s)
Ohira M, Oba S, Nakamura Y, Isogai E, Kaneko S, Nakagawa A, Hirata T, Kubo H, Goto T, Yamada S, Yoshida Y, Fuchioka M, Ishii S, Nakagawara A.
-
Journal Title
Cancer Cell 7
Pages: 337-350
Peer Reviewed
-
-
-
-
[Journal Article] LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma.2005
Author(s)
Aoyama M, Ozaki T, Inuzuka H, Tomotsune D, Hirato J, Okamoto Y, Tokita H, Ohira M, Nakagawara A.
-
Journal Title
Cancer Res. 65
Pages: 4587-4597
Peer Reviewed
-
-
-
-
-
[Journal Article] Meta-analysis of neuroblastomas reveals a skewed ALK mutations spectrum in tumors with MYCN amplification.
Author(s)
De Brouwer S, De Preter K, Kumps C, Westerhout E, Lakeman A, Hoebeeck J, Van Maerken T, Laureys G, Schulte JH, Noguera R, Delattre O, Janouiex-Lerosey I, Kogner P, Martinsson T, Nakagawara A, Ohira M, Caron H, Eggert A, Versteeg R, Speleman F.
-
Journal Title
J. Glin. Oncol. (Accepted)
Peer Reviewed
-